Last Updated: November 13, 2026

OFLOXACIN Drug Patent Profile

« Back to Dashboard

When do Ofloxacin patents expire, and when can generic versions of Ofloxacin launch?

Ofloxacin is a drug marketed by Bedford, Altaire Pharms Inc, Alvogen, Amneal, Apotex Inc, Bausch And Lomb, Caplin, Epic Pharma Llc, Fdc Ltd, Mankind Pharma, Micro Labs, Sandoz, Sentiss, Somerset, Bausch And Lomb Inc, Hikma, Somerset Theraps Llc, Cadila Pharms Ltd, Chartwell Rx, Dr Reddys Labs Ltd, Ranbaxy Labs Ltd, and Teva. and is included in thirty NDAs.

The generic ingredient in OFLOXACIN is ofloxacin. Thirty-two suppliers are listed for this compound. Additional details are available on the ofloxacin profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Ofloxacin

A generic version of OFLOXACIN was approved as ofloxacin by CHARTWELL RX on September 2^nd, 2003.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for OFLOXACIN?
What are the global sales for OFLOXACIN?
What is Average Wholesale Price for OFLOXACIN?

Summary for OFLOXACIN

US Patents:	0
Applicants:	22
NDAs:	30

US Patents and Regulatory Information for OFLOXACIN

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dr Reddys Labs Ltd	OFLOXACIN	ofloxacin	TABLET;ORAL	077098-001	Feb 10, 2006	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Cadila Pharms Ltd	OFLOXACIN	ofloxacin	TABLET;ORAL	091656-003	Sep 18, 2014	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Dr Reddys Labs Ltd	OFLOXACIN	ofloxacin	TABLET;ORAL	077098-002	Feb 10, 2006	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Chartwell Rx	OFLOXACIN	ofloxacin	TABLET;ORAL	076093-001	Sep 2, 2003		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Bedford	OFLOXACIN	ofloxacin	INJECTABLE;INJECTION	075762-001	Jan 16, 2002		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Apotex Inc	OFLOXACIN	ofloxacin	SOLUTION/DROPS;OTIC	076527-001	Sep 28, 2007	AT	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.